At BioRestorative Therapies, I lead enterprise Technical Operations across Manufacturing, Quality Assurance, Quality Control, Facilities, and Supply Chain. I oversee investigational product release, manufacturing quality, and facility readiness for development-stage bio-cosmeceutical programs.
As Director, Quality & Compliance / Site Head of Quality at BioRestorative Therapies, I led site Quality for Phase 2 cell therapy and preclinical programs. I oversaw Quality through the BRTX-100 Phase 2 manufacturing campaign and implemented in-house mycoplasma testing, reducing batch-record and clinical release cycle time.
At Bristol Myers Squibb, I served as site Business Process Owner and Subject Matter Expert for CAPA, investigations, and proactive Quality initiatives supporting commercial CAR-T products. I led migration of CAPA records into Veeva Vault QMS, completing it one month ahead of the global deadline.
Earlier, at AbbVie and Allergan, I worked across Quality Engineering, human tissue products, risk management, and manufacturing support. At Dendreon Corporation, I performed aseptic cGMP manufacturing of clinical and commercial cellular products and supported scale-up of an autologous cellular therapy from 12 to 48 workstations.

